213-OR: ADA presidents’ select abstract: EMBARK—A randomized, controlled trial comparing three approaches to reducing diabetes distress in adults with type 1 diabetes
The DOI matches its Crossref record.
Abstract
Diabetes distress (DD) refers to the fears, worries and burdens associated with the diabetes experience. DD is common, distinct from depression, and associated with glycemic and disease management. EMBARK is a randomized, controlled clinical trial comparing three interventions to reduce DD among adults with type 1 diabetes (T1D). Following baseline assessment, participants were randomly assigned to either: (1) Streamline, an educator-led education and management program, (2) TunedIn, a psychologist-led program focused exclusively on reducing DD, or (3) FixIt, an integration of StreamLine and TunedIn. All interventions were group-based (8 to 12 members) and virtual, including initial workshop(s), 1:1 phone calls, and follow-up meetings over a 4-month period. Recruitment occurred through clinics and community organizations in the U.S. Inclusion criteria were: T1D diagnosis, elevated DD (≥ 2.0 T1-DDS score), age ≥ 21 years, HbA1c ≥ 7.5% (58 mmol/mol), and English speaking. Regression analyses recorded change in DD from baseline to immediate post-intervention. A total of 300 adults with T1D participated (M±SD 46±15 years of age, 79% female, HbA1c 8.3%±0.9 (67 mmol/mol), T1-DDS score 2.8±0.8). Large and clinically meaningful reductions in total DD score occurred for each of the three study arms at follow-up (p < .001). The greatest DD reductions occurred in the FixIt intervention (Δ .88±.80), followed by TunedIn (Δ .59±.70), and then Streamline (Δ .48±.71); with DD reductions significantly greater in FixIt compared to Streamline (p = .005). The same pattern of results was evident in comparisons for the DD sources of Powerlessness (p < .001), Management (p = .06), Hypoglycemia (p = .009), and Physician Distress (p = .01). These preliminary findings highlight the benefit of focusing directly on the emotional side of diabetes to reduce DD and indicate that DD reductions are greatest when education and emotional DD-targeted interventions are integrated. Disclosure: D.M.Hessler: Consultant; Lilly. A.Ahmann: Advisory Panel; Medtronic. U.Masharani: Research Support; Clementia Pharmaceuticals. L.Fisher: Consultant; Abbott Diabetes, Eli Lilly and Company, Research Support; Ascensia Diabetes Care. L.A.Strycker: None. W.H.Polonsky: Consultant; Abbott Diabetes, Boehringer Ingelheim and Eli Lilly Alliance, Eli Lilly and Company, Insulet Corporation, Intuity Medical, Inc., MannKind Corporation, Provention Bio, Inc., Sanofi-Aventis U.S., Vertex Pharmaceuticals Incorporated. S.Guzman: Consultant; Abbott Diabetes. G.Aleppo: Advisory Panel; Medscape, Consultant; Bayer Inc., Insulet Corporation, Research Support; Dexcom, Inc., Eli Lilly and Company, Emmes, Insulet Corporation, Fractyl Health, Inc., WellDoc, Speaker's Bureau; Dexcom, Inc. E.Stephens: None. S.Kim: None. N.B.Argento: Advisory Panel; Dexcom, Inc., Eli Lilly and Company, ConvaTec Inc., Diabeloop SA, Senseonics, Speaker's Bureau; Dexcom, Inc., Boehringer Ingelheim and Eli Lilly Alliance, Novo Nordisk, MannKind Corporation, Zealand Pharma A/S, Xeris Pharmaceuticals, Inc., Eli Lilly and Company. Funding: National Institutes of Health (5R01DK121241)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These subscales were chosen based on brevity and prior use in a similar clinical trial (25) to facilitate cross-trial comparisons.”
From Addressing emotional distress to improve outcomes in adults with type 1 diabetes: Protocol for ACT1VATE randomized controlled trial (2024) · cites this paper as [25]
Citations
Cites
Still being checked.
Cited by
Kahkoska, A. R., Ercolino, G., Ortega, J., Fruik, A., Young, L., & Freeman, N. L. B. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01594-2 · Cited by 3
Soriano, E. C., Fortmann, A. L., Guzman, S. J., Sandoval, H., Spierling Bagsic, S. R., Bastian, A., Antrim, M., Chichmarenko, M., & Philis-Tsimikas, A. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107687 · Cited by 2
Self-citationTang, T. S. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.03.005 · Cited by 2
Depression in patients with diabetic retinopathy
Wenkert, D. (2024) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2024.2306779
Metadata
- Authors
- HESSLER, D. M., FISHER, L., STRYCKER, L. A., POLONSKY, W. H., GUZMAN, S., ALEPPO, G., STEPHENS, E., KIM, S., ARGENTO, N. B., AHMANN, A., & MASHARANI, U.
- Affiliations
- Eugene, OR, San Diego, CA, Chicago, IL, San Francisco, CA, Columbia, MD, Portland, OR
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2023-06-24
- Volume
- 72
- Issue
- Supplement_1
- ISSN
- 0012-1797 (ISSN-L)
- OpenAlex
- W4381853577
- Cited by
- 4
- References
- 0
- Citations by year
- 2025: 1 · 2024: 3
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- diabetes distress, type 1 diabetes, adults with diabetes, psychological intervention, diabetes self-management education, glycemic control, HbA1c, hypoglycemia, physician distress, powerlessness, EMBARK trial, patient-reported outcomes, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 213-OR: ADA presidents’ select abstract: EMBARK—A randomized, controlled trial comparing three approaches to reducing diabetes distress in adults with type 1 diabetes. https://app.cochat.ai/papers/10.2337/db23-213-or
- The paper
- HESSLER, D. M., FISHER, L., STRYCKER, L. A., POLONSKY, W. H., GUZMAN, S., ALEPPO, G., STEPHENS, E., KIM, S., ARGENTO, N. B., AHMANN, A., & MASHARANI, U. (2023). 213-OR: ADA presidents’ select abstract: EMBARK—A randomized, controlled trial comparing three approaches to reducing diabetes distress in adults with type 1 diabetes. Diabetes. https://doi.org/10.2337/db23-213-or
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.